Matthias Alder Gain Therapeutics, Inc. (GANX) insider trading activity

Matthias Alder is Chief Executive Officer of Gain Therapeutics, Inc.. Currently has a direct ownership of 21,140 shares of GANX, which is worth approximately $46,719. The most recent transaction as insider was on Mar 26, 2024, when has been sold 6,085 shares (Common Stock) at a price of $4.06 per share, resulting in proceeds of $24,705. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.1K

0% 3M change

216.7% 12M change

Total Value Held $46,719

Matthias Alder Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 26 2024	SELL Payment of exercise price or tax liability	$24,705 $4.06 p/Share	6,085 Reduced 22.35%	21,140 Common Stock
Mar 26 2024	BUY Exercise of conversion of derivative security	-	20,212 Added 42.61%	27,225 Common Stock
Dec 21 2023	SELL Open market or private sale	$506 $2.46 p/Share	206 Reduced 3.75%	5,286 Common Stock
Dec 20 2023	BUY Exercise of conversion of derivative security	-	637 Added 10.39%	5,492 Common Stock
Dec 07 2023	SELL Open market or private sale	$4,550 $2.5 p/Share	1,820 Reduced 27.27%	4,855 Common Stock
Oct 01 2023	BUY Exercise of conversion of derivative security	-	825 Added 11.0%	6,675 Common Stock
Sep 20 2023	BUY Exercise of conversion of derivative security	-	2,550 Added 30.36%	5,850 Common Stock
Jul 01 2023	BUY Exercise of conversion of derivative security	-	3,300 Added 50.0%	3,300 Common Stock

Matthias Alder

Chief Executive Officer

Bethesda, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GANX shares.

Notify only if

Value

Insider Trading

Get notified when an Gain Therapeutics, Inc. insider buys or sells GANX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Gain Therapeutics, Inc.

Track Activities on GANX

Account